| HCAT |
Health Catalyst, Inc. |
Common Stock, $0.01 par value |
19.68% |
$41.2M |
-$138K |
13.9M |
-0.33% |
Mathew P. Arens |
Dec 1, 2025 |
| PHLT |
Performant Healthcare, Inc. |
Common Stock, $0.01 par value |
16.36% |
$53.1M |
|
12.9M |
|
Mathew P. Arens |
Jun 30, 2025 |
| MASS |
908 Devices Inc. |
Common Stock, $0.001 par value |
12.93% |
$27.6M |
$6.6M |
4.68M |
+31.4% |
First Light Asset Management, LLC |
Nov 30, 2025 |
| AXGN |
Axogen, Inc. |
Common Stock, $0.01 par value |
12.88% |
$106M |
$23.5M |
5.94M |
+28.4% |
Mathew P. Arens |
Sep 30, 2025 |
| SIBN |
SI-BONE, Inc. |
Common Stock, $0.001 par value |
11.92% |
$93.1M |
|
5.17M |
|
Mathew P. Arens |
Nov 30, 2025 |
| KRMD |
KORU Medical Systems, Inc. |
Common Stock, $0.01 par value |
10.46% |
$12M |
$628K |
4.82M |
+5.51% |
Mathew P. Arens |
Apr 30, 2025 |
| NEO |
Neogenomics, Inc. |
Common Stock, $0.01 par value |
7.57% |
$73.3M |
|
9.78M |
|
Mathew P. Arens |
Jun 30, 2025 |
| ORGO |
Organogenesis Holdings, Inc. |
Common Stock, $0.01 par value |
6.55% |
$35.7M |
|
8.31M |
|
Mathew P. Arens |
Jun 30, 2025 |
| ANAB |
AnaptysBio Inc. |
Common Stock, $0.01 par value |
3.12% |
$26.5M |
-$42.9M |
865K |
-61.8% |
Mathew P. Arens |
Sep 30, 2025 |
| FNA |
Paragon 28, Inc. |
Common Stock, $0.01 par value |
1.7% |
$18.7M |
-$120M |
1.43M |
-86.5% |
Mathew P. Arens |
Feb 28, 2025 |
| OPRX |
OptimizeRx Corporation |
Common Stock, $0.01 par value |
0% |
$0 |
|
0 |
|
First Light Asset Management, LLC |
Dec 31, 2024 |